Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use
In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses his co-authored publication “Long-Acting Injectable Antipsychotics For Schizophrenia: Sociodemographic Characteristics & Treatment Adherence,” which published February 2017 in Primary Care Companion For CNS Disorders. Dr. McCreath shares his insights and perspectives on long-acting injectable antipsychotics (LAIs) in mental health, with Joe Cirrincione, PharmD, MBA, and Becky Wong, PharmD, MBA, members of the Otsuka Pharmaceutical Development & Commercialization, Inc. Field Medical …